CVS Health Corporation
NYSECVS Health heads into its May 14 earnings call with short sellers meaningfully rebuilding positions after a multi-week retreat — the most notable repositioning on the stock this side of April. The short-interest story here is genuinely interesting, even if the absolute level remains modest. Short interest has climbed roughly 6% over the past week to 1.35% of the free float — a clear…
Snapshot as of 6 May 2026
CVS Health heads into its May 14 earnings call with short sellers meaningfully rebuilding positions after a multi-week retreat — the most notable repositioning on the stock this side of April. The short-interest story…
CVS Health reports Q1 2026 results on May 6 as a stock that has quietly re-rated higher — and with the short sellers who drove much of the bearish narrative now stepping back. Short interest has fallen sharply over the…
CVS Health enters its May 6 earnings call in a notably better place than it left the last few months — up 15.5% over the past month and shedding short positions at pace, yet options traders are quietly loading up on…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CVS — free to start on ORTEX.
Sign up for free →Open CVS on ORTEX